Histone acetyltransferases interact with and acetylate p70 ribosomal S6 kinases in vitro and in vivo

被引:28
作者
Fenton, T. R. [1 ]
Gwalter, J. [1 ]
Ericsson, J. [3 ]
Gout, I. T. [1 ,2 ]
机构
[1] UCL, Res Dept Struct & Mol Biol, London WC1E 6BT, England
[2] Natl Acad Sci Ukraine, Inst Mol Biol & Genet, UA-03143 Kiev, Ukraine
[3] Uppsala Univ, Ludwig Inst Canc Res, Biomed Ctr, S-75124 Uppsala, Sweden
基金
英国生物技术与生命科学研究理事会;
关键词
S6; kinase; Acetyltransferase; HDAC inhibitor; CREB-BINDING PROTEIN; TRANSCRIPTIONAL COACTIVATOR; CELL-GROWTH; PHOSPHORYLATION; P300; BETA; CLONING; CANCER; UBIQUITINATION; TRANSLATION;
D O I
10.1016/j.biocel.2009.11.022
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The 70 kDa ribosomal protein S6 kinases (S6K1 and 56K2) play important roles in the regulation of protein synthesis, cell growth and survival. S6Ks are activated in response to mitogen stimulation and nutrient sufficiency by the phosphorylation of conserved serine and threonine residues. Here we show for the first time, that in addition to phosphorylation, S6Ks are also targeted by lysine acetylation. Following mitogen stimulation, S6Ks interact with the p300 and p300/CBP-associated factor (PCAF) acetyltransferases. S6Ks can be acetylated by p300 and PCAF in vitro and S6K acetylation is detected in cells expressing p300. Furthermore, it appears that the acetylation sites targeted by p300 lie within the divergent C-terminal regulatory domains of both S6K1 and S6K2. Acetylation of S6K1 and 2 is increased upon the inhibition of class I/II histone deacetylases (HDACs) by trichostatin-A, while the enhancement of S6K1 acetylation by nicotinamide suggests the additional involvement of sirtuin deacetylases in S6K deacetylation. Both expression of p300 and HDAC inhibition cause increases in S6K protein levels, and we have shown that S6K2 is stabilized in cells treated with HDAC inhibitors. The finding that S6Ks are targeted by histone acetyltransferases uncovers a novel mode of crosstalk between mitogenic signalling pathways and the transcriptional machinery and reveals additional complexity in the regulation of S6K function. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:359 / 366
页数:8
相关论文
共 50 条
  • [1] Functions and regulation of the 70 kDa ribosomal S6 kinases
    Fenton, Tim R.
    Gout, Ivan T.
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2011, 43 (01) : 47 - 59
  • [2] p70 Ribosomal protein S6 kinase (Rps6kb1): an update
    Bahrami-B, Farnaz
    Ataie-Kachoie, Parvin
    Pourgholami, Mohammad H.
    Morris, David L.
    JOURNAL OF CLINICAL PATHOLOGY, 2014, 67 (12) : 1019 - 1025
  • [3] Interferon-γ engages the p70 S6 kinase to regulate phosphorylation of the 40S S6 ribosomal protein
    Lekmine, F
    Sassano, A
    Uddin, S
    Smith, J
    Majchrzak, B
    Brachmann, SM
    Hay, N
    Fish, EN
    Platanias, LC
    EXPERIMENTAL CELL RESEARCH, 2004, 295 (01) : 173 - 182
  • [4] Exploiting p70 S6 kinase as a target for ovarian cancer
    Ip, Carman K. M.
    Wong, Alice S. T.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2012, 16 (06) : 619 - 630
  • [5] p70 S6 kinase and tau in Alzheimer's disease
    Pei, Jin-Jing
    Bjorkdahl, Cecilia
    Zhang, Haiyan
    Zhou, Xinwen
    Winblad, Bengt
    JOURNAL OF ALZHEIMERS DISEASE, 2008, 14 (04) : 385 - 392
  • [6] S6 PHOSPHORYLATION AND THE P70(S6K)/P85(S6K)
    FERRARI, S
    THOMAS, G
    CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1994, 29 (06) : 385 - 413
  • [7] Characterization of PF-4708671, a novel and highly specific inhibitor of p70 ribosomal S6 kinase (S6K1)
    Pearce, Laura R.
    Alton, Gordon R.
    Richter, Daniel T.
    Kath, John C.
    Lingardo, Laura
    Chapman, Justin
    Hwang, Catherine
    Alessi, Dario R.
    BIOCHEMICAL JOURNAL, 2010, 431 : 245 - 255
  • [8] Structural requirement of leucine for activation of p70 S6 kinase
    Shigemitsu, K
    Tsujishita, Y
    Miyake, H
    Hidayat, S
    Tanaka, N
    Hara, K
    Yonezawa, K
    FEBS LETTERS, 1999, 447 (2-3) : 303 - 306
  • [9] p70 S6 kinase as a therapeutic target in cancers: More than just an mTOR effector
    Artemenko, Margarita
    Zhong, Sophia S. W.
    To, Sally K. Y.
    Wong, Alice S. T.
    CANCER LETTERS, 2022, 535
  • [10] Glycogen synthase kinase (GSK)-3 promotes p70 ribosomal protein S6 kinase (p70S6K) activity and cell proliferation
    Shin, Sejeong
    Wolgamott, Laura
    Yu, Yonghao
    Blenis, John
    Yoon, Sang-Oh
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (47) : E1204 - E1213